Comparative pathology of dog and human prostate cancer

T Ryman‐Tubb, JH Lothion‐Roy… - Veterinary medicine …, 2022 - Wiley Online Library
Though relatively rare in dogs, prostate cancer (PCa) is the most common non‐cutaneous
cancer in men. Human and canine prostate glands share many functional, anatomical and …

[HTML][HTML] Advances in organoid technology for veterinary disease modeling

B Chen, RF Slocombe, SR Georgy - Frontiers in Veterinary …, 2023 - ncbi.nlm.nih.gov
Organoids are in vitro organ-like structures that faithfully recapitulate many characteristics of
a specific organ. During the past decades, major progress has been accomplished in …

MDR1 inhibition reverses doxorubicin-resistance in six doxorubicin-resistant canine prostate and bladder cancer cell lines

EM Packeiser, L Engels, I Nolte… - International Journal of …, 2023 - mdpi.com
Acquired chemoresistance during chemotherapy, often accompanied by cross-and multi-
resistance, limits therapeutic outcomes and leads to recurrence. In order to create in vitro …

An RNA-Seq-based framework for characterizing canine prostate cancer and prioritizing clinically relevant biomarker candidate genes

H Thiemeyer, L Taher, JT Schille, EM Packeiser… - International journal of …, 2021 - mdpi.com
Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In
contrast to the situation in humans, multi-gene approaches facilitating risk stratification of …

[HTML][HTML] Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a …

K Klose, EM Packeiser, P Müller, JL Granados-Soler… - PLoS …, 2021 - journals.plos.org
An important approach in tumor therapy is combining substances with different action
mechanisms aiming to enhance the antineoplastic effect, decrease the therapeutic dosage …

Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines

K Klose, EM Packeiser… - Veterinary and …, 2022 - Wiley Online Library
Canine prostate cancer is classified into adenocarcinoma, transitional cell carcinoma with
prostatic involvement, and mixed forms. Early metastatic spread leads to poor prognosis and …

Comparative pathobiology of canine and human prostate cancer: state of the art and future directions

EP Nascente, RL Amorim, CE Fonseca-Alves… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer (PC) is one of the main types of cancer that affects the
male population worldwide. In recent decades, there has been a significant evolution in the …

Ablation of red stable transfected claudin expressing canine prostate adenocarcinoma and transitional cell carcinoma cell lines by C-CPE gold-nanoparticle-mediated …

S Alnajjar, I Nolte, A Becker, JT Schille… - International journal of …, 2021 - mdpi.com
Claudin (CLDN) proteins are commonly expressed in cancers and targeted in novel
therapeutic approaches. The C-terminal of Clostridium perfringens enterotoxin (C-CPE) …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong, M Ernst, J Beck… - Cancer cell …, 2022 - Springer
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …

Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs

H Yamasaki, Y Uematsu, K Okano, M Ichikawa… - In Vitro Cellular & …, 2022 - Springer
Each 5 urothelial carcinoma (UC) cell lines with and without the v-Raf murine sarcoma virus
oncogene homolog B (BRAF) gene mutation (V595E) were established and examined …